Search results
Q1 2024 Acurx Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 40 minutes agoAntonio Eduardo Arce; MD of Equity Research & Senior Healthcare Analyst; H.C. Wainwright & Co, LLC, Research Division James Francis Molloy; MD of Equity Research and Biotechnology ...
Regenxbio shares target lifted by H.C. Wainwright, cites CAMPSIITE trial By Investing.com
Investing.com· 15 hours agoOn Wednesday, H.C. Wainwright adjusted its outlook on Regenxbio Inc. (NASDAQ:RGNX) shares,...
Delcath Systems shares target raised by H.C. Wainwright on strong Q1 earnings By Investing.com
Investing.com· 15 hours agoOn Wednesday, Delcath Systems Inc. (NASDAQ:DCTH) shares, received an updated price target from H.C. ...
Fennec Pharmaceuticals shares target cut by H.C.Wainwright amid sales short fall By Investing.com
Investing.com· 14 hours agoOn Wednesday, Fennec Pharmaceuticals Inc. (NASDAQ:FENC) shares experienced a revision in its...
HC Wainwright Equities Analysts Increase Earnings Estimates for Myomo, Inc. (NYSEAMERICAN:MYO)
ETF DAILY NEWS· 23 hours agoMyomo, Inc. (NYSEAMERICAN:MYO – Free Report) – HC Wainwright boosted their Q3 2024 earnings estimates for shares of Myomo in a report released on Thursday, May 9th. HC < ...
HC Wainwright Trims Mind Medicine (MindMed) (NASDAQ:MNMD) Target Price to $35.00
ETF DAILY NEWS· 3 days agoMind Medicine (MindMed) (NASDAQ:MNMD – Free Report) had its price objective reduced by HC Wainwright from $75.00 to $35.00 in a research note released on Friday morning, Benzinga ...
Capricor Therapeutics (NASDAQ:CAPR) Receives Buy Rating from HC Wainwright
ETF DAILY NEWS· 21 hours agoHC Wainwright reissued their buy rating on shares of Capricor Therapeutics (NASDAQ:CAPR – Free Report) in a research note released on Tuesday, Benzinga reports. HC
Braves Make Interesting Move in Latest 2024 MLB Mock Draft
Sports Illustrated· 11 hours agoThe Atlanta Braves have a “type” in the MLB Draft - college righthanders. In 2023, of their twelve...
HC Wainwright Reiterates Buy Rating for Novavax (NASDAQ:NVAX)
ETF DAILY NEWS· 23 hours agoNovavax (NASDAQ:NVAX – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a report released on Monday, Benzinga reports. HC ...
FY2024 EPS Estimates for First Majestic Silver Corp. (NYSE:AG) Cut by HC Wainwright
ETF DAILY NEWS· 22 hours agoFirst Majestic Silver Corp. (NYSE:AG – Free Report) (TSE:FR) – Equities research analysts at HC Wainwright lowered their FY2024 earnings estimates for shares of First Majestic ...
